Invention Application
- Patent Title: ADMINISTRATION OF NEUTRAL ENDOPEPTIDASE TO TREAT INFLAMMATORY BOWEL DISEASE
- Patent Title (中): 中性内皮抑素治疗炎症性皮肤病
-
Application No.: PCT/US2005/020516Application Date: 2005-06-10
-
Publication No.: WO2005123119A2Publication Date: 2005-12-29
- Inventor: THANOS, Christopher, D. , MADISON, Edwin, L.
- Applicant: CATALYST BIOSCIENCES, INC. , THANOS, Christopher, D. , MADISON, Edwin, L.
- Applicant Address: 290 Utah Avenue, South San Francisco, CA 94080 US
- Assignee: CATALYST BIOSCIENCES, INC.,THANOS, Christopher, D.,MADISON, Edwin, L.
- Current Assignee: CATALYST BIOSCIENCES, INC.,THANOS, Christopher, D.,MADISON, Edwin, L.
- Current Assignee Address: 290 Utah Avenue, South San Francisco, CA 94080 US
- Agency: ELRIFI, Ivor, R.
- Priority: US60/578,911 20040610
- Main IPC: A61K38/48
- IPC: A61K38/48
Abstract:
Administration of recombinant, truncated mammalian NEP or certain bacterial homologues of this protein is therapeutically effective in the treatment of inflammatory bowel disease.
Information query
IPC分类:
